April 18, 2014 4:59 PM ET

Biotechnology

Company Overview of AusAm Biotechnologies, Inc.

Company Overview

AusAm Biotechnologies, Inc. operates as a biotechnology research and development company. The company focuses on commercializing diagnostic and therapeutic products to identify and treat various diseases. It offers Accumin, an assay for the detection of intact albumin in urine, as well as for use in the diagnosis and treatment of disease conditions, such as renal or heart diseases, or thyroid disorders. AusAm Biotechnologies offers its products through reference laboratories and hospitals in the United States. The company was incorporated in 2000 and is based in New York, New York. On February 7, 2006, AusAm Biotechnologies, Inc. filed a voluntary petition for reorganization under Chapter 11...

645 Madison Avenue

Suite 502

New York, NY 10022

United States

Founded in 2000

Phone:

212-659-0703

Fax:

212-659-0707

Key Executives for AusAm Biotechnologies, Inc.

President and Director
Chief Financial Officer
Chief Operating Officer
Director of Clinical Trials and Director
Senior Research Coordinator
Compensation as of Fiscal Year 2013.

Similar Private Companies By Industry

Company Name Region
D-finitive Technologies, Inc. United States
Rinat Neuroscience Corporation United States
Dimension Therapeutics, Inc. United States
DNA Medical Technologies, Inc. United States
MatTek Corporation United States

Recent Private Companies Transactions

Type
Date
Target
No transactions available in the past 12 months.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

Most Searched Private Companies

Company Name Geographic Region
NYC2012, Inc. United States
Lawyers Committee for Civil Rights Under Law United States
Bertelsmann AG Europe
Rush University United States
Citizens Budget Commission United States

Post a JobJobs

View all jobs

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact AusAm Biotechnologies, Inc., please visit --. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.